Management of ET
Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts

Released: February 23, 2023

Expiration: February 22, 2024

Prithviraj Bose
Prithviraj Bose, MD
Andrew Kuykendall
Andrew Kuykendall, MD

Activity

Progress
1
Course Completed

In this podcast episode, Prithviraj Bose, MD, and Andrew Kuykendall, MD, discuss their contemporary approaches to the treatment of patients with essential thrombocythemia. The topics covered include:

  • When to use cytoreduction therapies and which therapies to use in low-risk patients
  • Type 1 and type 2 CALR mutations and addressing patient concerns with data from sequencing reports
  • Experts’ thoughts on therapy options in higher-risk patients